Squarepoint
EOLS icon

Squarepoint’s Evolus EOLS Stock Holding History

Squarepoint’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Sell
158,392
-15,954
-9% -$77.3K ﹤0.01% 3122
2025
Q4 		$1.16M Buy
174,346
+133,133
+323% +$902K ﹤0.01% 2481
2025
Q3 		$253K Sell
41,213
-64,584
-61% -$504K ﹤0.01% 3789
2025
Q2 		$974K Buy
105,797
+94,423
+830% +$966K ﹤0.01% 2683
2025
Q1 		$137K Sell
11,374
-14,805
-57% -$194K ﹤0.01% 4133
2024
Q4 		$289K Sell
26,179
-64,180
-71% -$902K ﹤0.01% 4175
2024
Q3 		$1.46M Buy
90,359
+19,861
+28% +$278K ﹤0.01% 2308
2024
Q2 		$765K Sell
70,498
-3,091
-4% -$38K ﹤0.01% 2753
2024
Q1 		$1.03M Sell
73,589
-47,055
-39% -$612K ﹤0.01% 2568
2023
Q4 		$1.27M Sell
120,644
-161,100
-57% -$1.44M ﹤0.01% 2350
2023
Q3 		$2.58M Buy
281,744
+139,659
+98% +$1.25M 0.01% 1624
2023
Q2 		$1.03M Buy
+142,085
New +$1.23M ﹤0.01% 2138
2022
Q4 		– Sell
-87,197
Closed -$702K – 3284
2022
Q3 		$702K Buy
87,197
+56,048
+180% +$594K ﹤0.01% 2000
2022
Q2 		$361K Buy
+31,149
New +$367K ﹤0.01% 2184
2021
Q4 		– Sell
-18,749
Closed -$143K – 3253
2021
Q3 		$143K Sell
18,749
-29,179
-61% -$302K ﹤0.01% 2597
2021
Q2 		$606K Buy
47,928
+34,897
+268% +$384K ﹤0.01% 1999
2021
Q1 		$169K Sell
13,031
-85,925
-87% -$792K ﹤0.01% 2764
2020
Q4 		$332K Buy
98,956
+88,845
+879% +$334K ﹤0.01% 2132
2020
Q3 		$40K Buy
+10,111
New +$36.9K ﹤0.01% 2386
2020
Q1 		– Sell
-76,646
Closed -$933K – 2029
2019
Q4 		$933K Buy
+76,646
New +$1.08M 0.01% 1371
2019
Q1 		– Sell
-29,799
Closed -$355K – 2220
2018
Q4 		$355K Sell
29,799
-2,131
-7% -$30.4K ﹤0.01% 1416
2018
Q3 		$595K Buy
+31,930
New +$692K 0.01% 1230

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's EOLS Position: Q1 2026 in Review

Squarepoint reduced its Evolus (EOLS) stake by 9.2% in Q1 2026, selling an estimated $77.3K and leaving 158,392 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

Squarepoint first reported a position in EOLS in Q3 2018 and has held it in 22 quarters since. The position peaked at $2.58M in Q3 2023. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Squarepoint held 158,392 shares of Evolus worth $651K as of Q1 2026.
  • Squarepoint sold 15,954 Evolus shares in Q1 2026, an estimated $77.3K.
  • Evolus made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3122 holding.
  • Squarepoint first reported a position in Evolus in Q3 2018 and has held it in 22 quarters since.
  • Squarepoint's Evolus position peaked at $2.58M in Q3 2023.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.